The implant is designed for use in breast reconstruction, augmentation or revision surgeries and was created using a new gel to achieve medium firmness.
The approval marks the third firmness option for Allergan’s breast implant portfolio.
More articles on supply chain:
Why driverless cars could magnify the organ donor shortage
Amazon’s newest endeavor: A floating warehouse
How ‘phantom inventory’ could be hurting your supply chain
